Kyle Michael Wool, Director at AIkido Pharma Inc. (AIKI), bought 47,424 shares at $6.32 ($300K) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market purchase of $300k AIKI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.32 | 23,712 | $150K | 50.0% |
| 2 | $6.32 | 23,712 | $150K | 50.0% |
| Total | $6.32 avg | 47,424 | $300K | 100% |
| Filing → |
| DOMH | BUY | 2025-12-10 | $97K | — | Filing → |
| DOMH | BUY | 2024-05-31 | $11K | — | Filing → |
| DOMH | BUY | 2024-04-10 | $13K | — | Filing → |